ERBB2 and breast cancer: These findings suggest that fatty acid metabolism is more vigorous in HER2-positive breast cancer, and elevated fatty acid metabolic pathway is a consistent trait in HER2-positive breast cancer cells and tissues that are resistant to anti-HER2 treatment.